Abstract
Minimally invasive surgery (MIS) has already had a significant impact on surgical treatment (spine). Because they are less invasive, minimally invasive treatments are often preferred over open spine surgery. MIS and open spine surgery in terms of posterior lumbar fusion (PLF), lumbar disc herniation (LDH), and cervical disc herniation (CDH) were all observational studies based on randomized controlled trials. Seventeen RCTs and six observational studies were conducted. Chemotherapy had no effect on the long-term alleviation of the neck or arm pain in patients with CDH. In LDH, MIS was superior in terms of pain relief, rehospitalization rates, and improvement in quality of life. At the expense of increased perioperative endoscopic, readmission, and revision rates, MIS achieved a significant reduction in 2-year expenditures, fewer medical problems, and improved Oswestry score ratings. There is no evidence to support the use of MIS over open surgery for lumbar or cervical process disc herniation. In comparison, MIS-TLIF has several advantages, in addition to lower revision/readmission rates. However, MIS significantly increases the surgeon's radiation exposure, regardless of the patient's sign. However, the effect on patients is unknown. These findings could help patients make better decisions when comparing open spine surgery to minimally invasive spine surgery, especially given how much advertising is out there for MIS.